Search of: "Atazanavir"[TREATMENT] AND HIV [CONDITION] - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 83 studies with search of:

"Atazanavir"[TREATMENT] AND HIV [CONDITION]

Hide studies that are not seeking new volunteers.

Display Options

1	Completed	Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
		Condition:	HIV Infections
		Interventions:	Drug: Rosiglitazone maleate; Drug: Atazanavir Sulphate; Drug: Atazanavir Sulphate + Rosiglitazone maleate; Drug: Atazanavir Sulphate + Ritonavir; Drug: Atazanavir Sulphate + Ritonavir + Rosiglitazone maleate

2	Completed	Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir+Ritonavir+Tenofovir; Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine; Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine; Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine; Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine

3	Active, not recruiting	Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV Infected Infants, Children, and Adolescents
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Ritonavir

4	Completed	Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir/ Stavidine / Lamivudine; Drug: Atazanavir-Ritonavir/ Stavidine / Lamivudine

5	Completed	Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir + 2 NRTIs; Drug: Atazanavir + Ritonavir + 2 NRTIs

6	Completed	A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir (immediate switch); Drug: Atazanavir (Week 24 switch)

7	Recruiting	SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
		Conditions:	HIV Infections; Lipodystrophy
		Interventions:	Drug: atazanavir (Reyataz); Drug: ritonavir (Norvir)

8	Completed	DDI HV (ATV - Merck)
		Condition:	HIV Infections
		Interventions:	Drug: Raltegravir; Drug: Atazanavir; Drug: Atazanavir + Raltegravir

9	Completed	Study of Reyataz in HIV-Infected Patients With Lipodystrophy Syndrome
		Condition:	HIV-Associated Lipodystrophy Syndrome
		Interventions:	Drug: Atazanavir + ritonavir; Drug: boosted PI combination

10	Recruiting	Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
		Condition:	HIV Infections
		Interventions:	Drug: Nevirapine; Drug: Efavirenz; Drug: Indinavir/ritonavir; Drug: Nelfinavir; Drug: Saquinavir/ritonavir; Drug: Lopinavir/ritonavir; Drug: Atazanavir; Drug: Atazanavir/ritonavir; Drug: Fos-amprenavir/ritonavir; Drug: Tipranavir/ ritonavir; Drug: Darunavir/ritonavir

11	Recruiting	Metabolic Effects of Switching Kaletra to Boosted Reyataz
		Condition:	HIV Infections
		Interventions:	Drug: atazanavir/ritonavir; Drug: lopinavir/ritonavir

12	Completed	A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
		Condition:	HIV Infection
		Interventions:	Drug: Trizivir; Drug: atazanavir; Drug: Combivir

13	Recruiting	Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
		Condition:	HIV Infections
		Interventions:	Drug: lamivudine, abacavir , ritonavir, atazanavir; Drug: emtricitabine, tenofovir, ritonavir, atazanavir

14	Active, not recruiting	Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
		Condition:	HIV Infection
		Interventions:	Drug: atazanavir arm; Drug: efavirenz

15	Active, not recruiting	Study to Evaluate the Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Infected Subjects Evidencing Virologic Suppression
		Condition:	HIV Infections
		Intervention:	Drug: Atazanavir + Ritonavir

16	Active, not recruiting	Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Ritonavir; Drug: Tenofovir/emtricitabine

17	Suspended	Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
		Condition:	HIV Infection
		Interventions:	Drug: atazanavir; Drug: lopinavir/ritonavir

18	Active, not recruiting	Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women
		Condition:	HIV Infections
		Intervention:	Drug: Atazanavir + Ritonavir + Combivir

19	Terminated	Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients
		Condition:	HIV Infections
		Interventions:	Drug: Tenofovir; Drug: Atazanavir; Drug: Ritonavir

20	Completed	Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females
		Condition:	HIV Infections
		Interventions:	Drug: Ortho Tri-Cyclen (ethinyl estradiol + norgestimate); Drug: Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 days

21	Recruiting	Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
		Condition:	HIV Infections
		Interventions:	Drug: atazanavir/ritonavir; Drug: darunavir/ritonavir

22	Completed	Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir/Ritonavir; Drug: Atazanavir/Ritonavir + Famotidine; Drug: Atazanavir/Ritonavir + Famotidine; Drug: Atazanavir/Ritonavir; Drug: Atazanavir/Ritonavir + Tenofovir Disproxil Fumrarate + Famotidine; Drug: Atazanavir/Ritonavir + Tenofovir Disproxil Fumrarate + Famotidine

23	Active, not recruiting	"The Once A Day Protease Inhibitor Regimens"
		Conditions:	HIV Infections; Antiretroviral Therapy
		Interventions:	Drug: ritonavir-boosted atazanavir; Drug: ritonavir-boosted fosamprenavir

24	Completed	Drug Interaction Study With Proton Pump Inhibitor
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Atazanavir/Ritonavir; Drug: Atazanavir/Ritonavir+Omeprazole; Drug: Atazanavir/Ritonavir+Omeprazole; Drug: Atazanavir; Drug: Atazanavir/Ritonavir; Drug: Atazanavir/Ritonavir+Omeprazole; Drug: Atazanavir/Ritonavir+Omeprazole

25	Completed	Atazanavir Twice Daily
		Conditions:	HIV Infections; Protease Inhibitor
		Interventions:	Drug: Atazanavir Sulphate; Drug: Atazanavir Sulphate; Drug: Atazanavir Sulphate

26	Terminated	A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Nelfinavir mesylate

27	Active, not recruiting	Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir + ritonavir + tenofovir + nucleoside; Drug: Atazanavir + saquinavir + tenofovir + nucleoside; Drug: Lopinavir/ritonavir + tenofovir + nucleoside

28	Completed	A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Lamivudine/Zidovudine; Drug: Efavirenz

29	Completed	Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects
		Conditions:	HIV Infections; Protease Inhibitor
		Interventions:	Drug: Atazanavir Sulphate + Ritonavir; Drug: Atazanavir Sulphate + Ritonavir + Efavirenz

30	Completed	ATV/Ritonavir Nevirapine Interaction (USPAC)
		Condition:	HIV Infections
		Interventions:	Drug: Nevirapine; Drug: Nevirapine + Atazanavir/Ritonavir; Drug: Nevirapine + Atazanavir/Ritonavir; Drug: Atazanavir + Ritonavir

31	Not yet recruiting	Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
		Condition:	HIV Infections
		Interventions:	Drug: Raltegravir and truvada; Drug: Atazanavir, Norvir and Truvada

32	Active, not recruiting	Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study
		Conditions:	HIV Infection; Hyperlipidemia
		Interventions:	Drug: Atazanavir; Drug: current antiretroviral regimen

33	Completed	Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir (Reyataz); Drug: Ritonavir (Norvir); Drug: Nevirapine (Viramune)

34	Completed	Bioequivalence Study of Atazanavir 300 mg Capsule
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir + Ritonavir; Drug: Atazanavir + Ritonavir

35	Completed	Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
		Conditions:	HIV Infections; Dyslipidemia
		Intervention:	Drug: ATAZANAVIR

36	Active, not recruiting	Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
		Conditions:	HIV Infections; Tuberculosis
		Interventions:	Drug: Atazanavir; Drug: Rifampin; Drug: Ritonavir

37	Completed	Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
		Condition:	HIV Infections
		Interventions:	Drug: Truvada; Drug: atazanavir; Drug: ritonavir

38	Recruiting	BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes
		Condition:	HIV Infections
		Interventions:	Drug: saquinavir/ritonavir; Drug: atazanavir/ritonavir

39	Completed	A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-Based HAART Regimens in HIV-Infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-Containing HAART Regimen
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir+ritonavir; Drug: Lopinavir+ritonavir

40	Completed	Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Nelfinavir mesylate; Drug: Stavudine; Drug: Didanosine

41	Completed	Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Ritonavir; Drug: Saquinavir

42	Not yet recruiting	Atazanavir or Lopinavir in HIV Post-Exposure Prophylaxis
		Condition:	HIV Infections
		Interventions:	Drug: Combivir+Kaletra; Drug: Combivir+Reyataz

43	Completed	Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
		Conditions:	Hyperlipidemia; HIV Infections
		Intervention:	Drug: Atazanavir

44	Active, not recruiting	BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada
		Condition:	HIV Infections
		Interventions:	Drug: Reyataz + Ritonavir + Truvada; Drug: Kaletra + Truvada

45	Recruiting	Standard Antiretroviral Versus Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Emtricitabine/tenofovir DF; Drug: Maraviroc; Drug: Raltegravir

46	Recruiting	Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
		Condition:	HIV Infections
		Intervention:	Drug: Raltegravir and Atazanavir

47	Recruiting	Preventing Sexual Transmission of HIV With Anti-HIV Drugs
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Didanosine; Drug: Efavirenz; Drug: Emtricitabine/Tenofovir disoproxil fumarate; Drug: Lamivudine; Drug: Lopinavir/Ritonavir; Drug: Nevirapine; Drug: Stavudine; Drug: Tenofovir disoproxil fumarate; Drug: Zidovudine/Lamivudine

48	Completed	Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
		Condition:	HIV Infections
		Interventions:	Drug: Atazanavir; Drug: Lopinavir/Ritonavir

49	No longer available	Atazanavir for HIV Infected Individuals: An Early Access Program
		Condition:	HIV Infections
		Intervention:	Drug: Atazanavir (BMS-232632)

50	Active, not recruiting	Evaluation of Atazanavir Substitution Intervention (EASI) Study
		Condition:	HIV Infections
		Intervention:

Studies Shown (1-50)

Next (51-83)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options